WestView Capital Partners backs Helio Health Group
The transaction is WestView Capital Partners' eighth life sciences services and technology investment, adding to a $2.7 billion five-fund growth equity program.
WestView Capital Partners acquired Helio Health Group, AI-enabled compliance, government pricing, and commercialization services for life sciences.
Based in Morristown, N.J., Helio Health Group serves pharmaceutical, biotechnology and healthcare companies working through commercial contracting, regulatory and operational issues.
“This partnership represents an important milestone for HELIO,” said Manny Tzavlakis, Managing Partner of Helio Health Group.
Marci Juneau, John Poulin and Manny Tzavlakis will continue to lead the business and retain significant ownership under the minority partnership.
The capital is slated for hiring, service-line development, AI-enabled offerings and potential acquisitions tied to the company's existing areas of expertise.
Terms were not disclosed; Simpson Thacher & Bartlett LLP advised Helio Health Group, and Latham & Watkins LLP advised WestView Capital Partners.